Detalles de la búsqueda
1.
A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation.
Am J Transplant
; 20(1): 172-180, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31397943
2.
The MOBILE Study-A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain.
Pain Med
; 18(12): 2388-2400, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28383710
3.
A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder.
J Psychopharmacol
; 37(2): 144-154, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738100
4.
A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABAB receptor, and morphine in recreational opioid users.
J Psychopharmacol
; 37(5): 449-461, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37125424
5.
Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
J Pain Res
; 13: 3355-3369, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33328761
6.
A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy.
Clin Pharmacol Drug Dev
; 5(4): 259-68, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27310327
7.
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.
Clin Pharmacol Drug Dev
; 5(5): 408-25, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27410490
Resultados
1 -
7
de 7
1
Próxima >
>>